(Q44647738)

English

Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

immune challenge

1 reference

based on heuristic

inferred from title

Bernardo Castellano

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

E Romero

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

C Guaza

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

J Borrell

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

15 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Molecular Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

372-383

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Schizophrenia as a disorder of neurodevelopment

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

The neurodevelopmental model of schizophrenia: update 2005.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

In utero infection and adult schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Maternal infections and subsequent psychosis among offspring.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Distinct expression and distribution of vesicular proteins in the hippocampus of TNFa-deficient mice during development

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Maternal modulation of neonatal immune system development

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Prepulse inhibition of the acoustic startle reflex using visual and auditory prepulses: disruption by apomorphine.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

GAP-43: an intrinsic determinant of neuronal development and plasticity

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Maturation of prestimulation-induced startle modulation in girls

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Maturation of startle modulation

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

The adolescent brain and age-related behavioral manifestations

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Maternal immune activation alters fetal brain development through interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Sex differences in prepulse inhibition deficits in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Dopamine D1 receptor development depends on endogenous dopamine.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

The developing prefrontal cortex: is there a transient interneuron that stimulates catecholamine terminals?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Sex differences in dopamine receptor overproduction and elimination

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Critical appraisal of DNA microarrays in psychiatric genomics.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Childhood-onset schizophrenia. Progressive ventricular change during adolescence

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Childhood-onset schizophrenia: progressive brain changes during adolescence

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

In vivo evidence for post-adolescent brain maturation in frontal and striatal regions

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Low GSK-3 activity in frontal cortex of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Penetration of interleukin-6 across the murine blood-brain barrier

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Interleukin-2 does not cross the blood-brain barrier by a saturable transport system

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Inflammation-related genes up-regulated in schizophrenia brains

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

IL-2/15 receptor-beta gene deletion alters neurobehavioral performance

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

21 January 2018

Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of synaptophysin enhances neurotransmitter secretion at Xenopus neuromuscular synapses

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Prepulses inhibit startle-induced reductions of extracellular dopamine in the nucleus accumbens of rat.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunity and schizophrenia: autoimmunity, cytokines, and immune responses

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of immune function in schizophrenia: an overview

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of Neuropathologic Abnormalities Associated with Blood-Brain Barrier Breakdown in Transgenic Mice Expressing lnterleukin-6 in Astrocytes

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in negative symptoms of schizophrenia with antibodies to tumor necrosis factor-alpha and to interferon-gamma: a case report

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.44

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MP.2008.44

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44647738&oldid=2206816552"